Harvest One launches Satipharm reformulated CBD capsules in Europe


Harvest One Cannabis Inc. reports the company’s wholly owned medical subsidiary, Satipharm Ltd., has launched European sales of its recently reformulated CBD capsules. “The first product to market is the Satipharm 10 mg CBD Gelpell® capsule that provides superior bioavailability and quality,” notes a press release from Harvest One, a global cannabis company that develops and provides lifestyle and wellness products to consumers and patients in regulated markets around the world. They are currently available online at www.satipharm.com. Bricks and mortar distribution of the capsules “will follow with major retailers throughout the United Kingdom and European Union, with Canadian distribution…
Source: 4:20intel.com
Harvest One launches Satipharm reformulated CBD capsules in Europe